TIRBANIBULIN

TIRBANIBULIN was reported 249 times

TIRBANIBULIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE ALOPECIA 1 0.0182
1 APPLICATION SITE ABSCESS 1 0.0172
2 SECOND DEGREE CHEMICAL BURN OF SKIN 1 0.0167
3 POIKILODERMA 1 0.0093
4 POST INFLAMMATORY PIGMENTATION CHANGE 4 0.0088
5 ADMINISTRATION SITE DISCOLOURATION 1 0.0080
6 SWELLING OF NOSE 1 0.0058
7 APPLICATION SITE HYPOAESTHESIA 1 0.0043
8 APPLICATION SITE EXFOLIATION 17 0.0041
9 APPLICATION SITE SCAB 7 0.0032
10 APPLICATION SITE DRYNESS 10 0.0029
11 APPLICATION SITE VESICLES 16 0.0025
12 APPLICATION SITE DISCHARGE 2 0.0017
13 APPLICATION SITE DISCOLOURATION 7 0.0017
14 APPLICATION SITE ERYTHEMA 36 0.0014
15 LIP ERYTHEMA 1 0.0013
16 APPLICATION SITE SWELLING 6 0.0012
17 RECALL PHENOMENON 1 0.0012
18 SEROUS RETINAL DETACHMENT 1 0.0012
19 PERIORBITAL PAIN 1 0.0012
20 ACTINIC KERATOSIS 3 0.0012
21 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 1 0.0011
22 SKIN TEXTURE ABNORMAL 1 0.0010
23 APPLICATION SITE BRUISE 1 0.0010
24 NASAL PRURITUS 1 0.0008
25 APPLICATION SITE WARMTH 1 0.0008
26 APPLICATION SITE PARAESTHESIA 1 0.0008
27 FEELING GUILTY 1 0.0008
28 APPLICATION SITE INFLAMMATION 1 0.0007
29 APPLICATION SITE PAIN 13 0.0006
30 PANCREATIC CYST 1 0.0005
31 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
32 CHAPPED LIPS 2 0.0005
33 APPLICATION SITE PRURITUS 10 0.0004
34 SKIN TIGHTNESS 2 0.0004
35 DERMAL CYST 1 0.0004
36 EYELID IRRITATION 1 0.0004
37 CHEMICAL BURN OF SKIN 1 0.0004
38 SKIN WRINKLING 1 0.0004
39 APPLICATION SITE HAEMORRHAGE 1 0.0004
40 RHINALGIA 1 0.0004
41 LIP PAIN 1 0.0003
42 SQUAMOUS CELL CARCINOMA 3 0.0003
43 SWELLING OF EYELID 2 0.0003
44 APPLICATION SITE RASH 4 0.0003
45 SKIN REACTION 4 0.0003
46 PARADOXICAL DRUG REACTION 1 0.0003
47 APPLICATION SITE IRRITATION 3 0.0002
48 DIVERTICULUM INTESTINAL 1 0.0002
49 ROSACEA 1 0.0002
50 DRUG INTOLERANCE 20 0.0002
51 APPLICATION SITE BURN 1 0.0002
52 ERYSIPELAS 1 0.0002
53 SKIN NECROSIS 1 0.0002
54 BASAL CELL CARCINOMA 3 0.0002
55 ADVERSE DRUG REACTION 17 0.0002
56 PAIN OF SKIN 5 0.0002
57 PHOTOSENSITIVITY REACTION 3 0.0002
58 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
59 BLISTER 10 0.0002
60 MOUTH SWELLING 1 0.0002
61 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
62 HERPES SIMPLEX 1 0.0002
63 APPLICATION SITE REACTION 1 0.0001
64 HYPOPHOSPHATAEMIA 1 0.0001
65 SWOLLEN TONGUE 4 0.0001
66 ULCER 2 0.0001
67 ASPHYXIA 1 0.0001
68 ERYTHEMA 25 0.0001
69 SECOND PRIMARY MALIGNANCY 1 0.0001
70 LIP SWELLING 4 0.0001
71 SKIN PLAQUE 1 0.0001
72 CARDIOVASCULAR DISORDER 3 0.0001
73 BURNING SENSATION 8 0.0001
74 FACIAL PAIN 1 0.0001
75 SKIN BURNING SENSATION 8 0.0001
76 LIP DRY 1 0.0001
77 UROSEPSIS 1 0.0001
78 SWELLING FACE 7 0.0001
79 PRODUCT PACKAGING ISSUE 1 0.0001
80 PHARYNGEAL SWELLING 1 0.0001
81 TENDERNESS 1 0.0001
82 DERMATITIS 2 0.0001
83 SCAB 1 0.0001
84 NEOPLASM 1 0.0001
85 RASH MACULAR 3 0.0001
86 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
87 HYPERLIPIDAEMIA 1 0.0001
88 BLOOD PRESSURE FLUCTUATION 2 0.0001
89 NODULE 1 0.0001
90 SKIN EXFOLIATION 6 0.0001
91 BRONCHOSPASM 1 0.0001
92 PARAESTHESIA ORAL 1 0.0001
93 OSTEOPENIA 1 0.0001
94 SKIN IRRITATION 3 0.0001
95 BRAIN FOG 1 0.0001
96 OCULAR HYPERAEMIA 3 0.0001
97 SCAR 1 0.0001
98 HEAD DISCOMFORT 1 0.0001
99 DRUG ERUPTION 1 0.0001
100 EYE SWELLING 2 0.0001
101 GASTRIC ULCER 1 0.0001
102 TASTE DISORDER 1 0.0000
103 DISCOMFORT 3 0.0000
104 EATING DISORDER 1 0.0000
105 ORAL PAIN 1 0.0000
106 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
107 PRODUCT USE ISSUE 8 0.0000
108 DISEASE RECURRENCE 2 0.0000
109 NEURALGIA 1 0.0000
110 DIPLOPIA 1 0.0000
111 RASH PRURITIC 2 0.0000
112 DRUG INEFFECTIVE 48 0.0000
113 WOUND 1 0.0000
114 EYE PAIN 2 0.0000
115 HERPES ZOSTER 2 0.0000
116 EYE IRRITATION 2 0.0000
117 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
118 HYPERSENSITIVITY 6 0.0000
119 PRURITUS 12 0.0000
120 VIRAL INFECTION 1 0.0000
121 SKIN DISORDER 1 0.0000
122 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
123 PARAESTHESIA 4 0.0000
124 ABNORMAL BEHAVIOUR 1 0.0000
125 DISORIENTATION 1 0.0000
126 ANGIOEDEMA 1 0.0000
127 SKIN DISCOLOURATION 1 0.0000
128 RASH ERYTHEMATOUS 1 0.0000
129 HEART RATE INCREASED 2 0.0000
130 INFLAMMATION 1 0.0000
131 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
132 OEDEMA 1 0.0000
133 ANAPHYLACTIC REACTION 1 0.0000
134 OFF LABEL USE 15 0.0000
135 VERTIGO 1 0.0000
136 FEELING HOT 1 0.0000
137 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
138 EXPOSURE DURING PREGNANCY 1 0.0000
139 RASH 7 0.0000
140 DRY SKIN 2 0.0000
141 INJURY 1 0.0000
142 HOT FLUSH 1 0.0000
143 URTICARIA 2 0.0000
144 INTENTIONAL PRODUCT MISUSE 1 0.0000
145 MUSCULOSKELETAL STIFFNESS 1 0.0000
146 INSOMNIA 3 0.0000
147 SUICIDAL IDEATION 1 0.0000
148 ADVERSE EVENT 1 0.0000
149 SWELLING 1 0.0000
150 PRODUCT DOSE OMISSION ISSUE 3 0.0000
151 FLUSHING 1 0.0000
152 HYPERTENSION 2 0.0000
153 INCORRECT DOSE ADMINISTERED 2 0.0000
154 EMOTIONAL DISTRESS 1 0.0000
155 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
156 HEADACHE 5 0.0000
157 PSORIASIS 1 0.0000
158 NAUSEA 6 0.0000
159 CONDITION AGGRAVATED 2 0.0000
160 PAIN 4 0.0000
161 ASTHENIA 2 0.0000
162 GAIT DISTURBANCE 1 0.0000
163 BACK PAIN 1 0.0000
164 DIZZINESS 2 0.0000
165 PYREXIA 1 0.0000
166 ARTHRALGIA 1 0.0000
167 DIARRHOEA 1 0.0000
168 FATIGUE 1 0.0000
169 DEATH 1 0.0000